These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 227218)

  • 21. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Abnormal serum VLDL-IDL contents and changes in PHLA (LPH and H-TGL activities) in patients on hemodialysis].
    Yukawa S; Morishita S; Miyai T; Maeda T; Takahashi T; Kinoshita M; Miura K; Mune M; Yamada Y; Nomoto H
    Nihon Jinzo Gakkai Shi; 1983 Jun; 25(6):717-22. PubMed ID: 6663834
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L; Karádi I; Rozenberczki M; Kammerer L
    Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women.
    Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C
    Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes.
    Ericsson M; Johnson O; Tollin C; Furberg B; Backman C; Angquist K
    Scand J Rehabil Med; 1982; 14(4):209-12. PubMed ID: 7178868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental hyperthyroidism in man: effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase.
    Hansson P; Valdemarsson S; Nilsson-Ehle P
    Horm Metab Res; 1983 Sep; 15(9):449-52. PubMed ID: 6642415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
    Goldberg AP; Applebaum-Bowden DM; Bierman EL; Hazzard WR; Haas LB; Sherrard DJ; Brunzell JD; Huttunen JK; Ehnholm C; Nikkila EA
    N Engl J Med; 1979 Nov; 301(20):1073-6. PubMed ID: 226883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid relation ships in dialysis and renal transplant patients.
    Nicholls AJ; Cumming AM; Catto GR; Edward N; Engeset J
    Q J Med; 1981; 50(198):149-60. PubMed ID: 7029600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change of plasma lipoproteins by heparin-released lipoprotein lipase.
    Yang JY; Kim TK; Koo BS; Park BH; Park JW
    Exp Mol Med; 1999 Jun; 31(2):60-4. PubMed ID: 10410303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid metabolism in acute renal failure.
    Druml W; Laggner A; Widhalm K; Kleinberger G; Lenz K
    Kidney Int Suppl; 1983 Dec; 16():S139-42. PubMed ID: 6588244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The preheparin and postheparin lipids of high density lipoprotein subfractions: relation to the serum insulin and postheparin plasma lipase activities in normal human.
    Skottová N; Vaverková H; Vecera R; Bartek J
    Acta Univ Palacki Olomuc Fac Med; 1992; 134():69-74. PubMed ID: 1364970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of furosemide on the lipid abnormalities in chronic renal failure.
    Pasternack A; Leino T; Solakivi-Jaakkola T; Huttunen JK; Ehnholm C
    Acta Med Scand; 1983; 214(2):153-7. PubMed ID: 6624545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperlipidemia in rats with chronic renal failure].
    Nikiforova NV; Tananaeva IK; Pozdniakov AL; Sokolovskaia IV
    Biull Eksp Biol Med; 1978 Jun; 85(6):676-9. PubMed ID: 208685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J; Fischer M; Tschabitscher H
    Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].
    László A; Csalánosiné Németh M; Joó I; Kiss E; Havass Z; Szenohradszki P
    Orv Hetil; 1986 May; 127(19):1129-31. PubMed ID: 3714258
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipoprotein binding and hypertriglyceridemia in chronic uremia.
    Samar RE; Moncrief JW; Decherd JF; Popovich RP
    Trans Am Soc Artif Intern Organs; 1975; 21():455-63. PubMed ID: 167492
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipoprotein lipids in chronic renal failure and haemodialysis. The influence of etiology and implications for atherogenesis.
    Somer JB; Aitken JM; Abbott LK; Charlesworth JA; Macdonald G; Blacket RB
    Atherosclerosis; 1979 Dec; 34(4):353-63. PubMed ID: 229878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.